6505--VA San Diego Lymphoseek IDIQ
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA), Network Contracting Office (NCO) 22, has issued a Special Notice indicating its intent to award a sole source contract to Cardinal Health 414, LLC for 99mTC Tilmanocept (Lymphoseek®) UD 4 syringes. This is for the VA San Diego Healthcare System. Capabilities statements from interested parties are due by March 5, 2026.
Opportunity Details
This Notice of Intent (NOI) is published under Federal Acquisition Regulation (FAR) Subpart 5.101 and FAR Part 6.103-1, citing "only one responsible source." It is not a request for competitive quotes or proposals. The VA San Diego Healthcare System Nuclear Medicine Service requires Lymphoseek for the localization of lymph nodes prior to definitive surgery and treatment of patients with melanoma or other cancers.
Contract & Timeline
- Type: Notice of Intent to Sole Source (Delivery Order under FAR Part 6 and 12)
- Intended Contractor: Cardinal Health 414, LLC
- Product: 99mTC Tilmanocept (Lymphoseek®) UD 4 syringes
- NAICS Code: 325412 (Pharmaceutical Preparation Manufacturing)
- FSC Code: 6505 (Drugs and Biologicals)
- SBA Size Standard: 1,300 Employees
- Place of Performance: VA San Diego Healthcare System, San Diego, CA
- Period of Performance:
- Base: April 1, 2026 - March 31, 2027 (25 EA)
- Option Year 1: April 1, 2027 - March 31, 2028 (25 EA)
- Option Year 2: April 1, 2028 - March 31, 2029 (25 EA)
- Option Year 3: April 1, 2029 - March 31, 2030 (25 EA)
- Option Year 4: April 1, 2030 - March 31, 2031 (25 EA)
- Published Date: February 26, 2026
Submission Requirements
This notice is for informational purposes only; no solicitation document is available. Interested parties must submit clear and compelling evidence in a capabilities statement demonstrating they can provide the same items/services and that competition would be advantageous to the Government.
- Response Due: March 5, 2026, 10:00 AM Pacific Local Time
- Submission Method: Email to Hestia Sim (Hestia.Sim@va.gov) with subject: "RESPONSE TO INTENT TO SOLE SOURCE Lymphoseek"
- The government will not be responsible for costs incurred by respondents. A determination not to compete is at the government's discretion.